|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.51 CNY | -2.23% |
|
-7.11% | -0.62% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.14% | 5.67% | 13.43x | 2.52x | 0.55x | 4.37x | 7.21x | 2.95B | |
| -.--% | -.--% | 18.24x | 1.61x | 0.77x | 12.2x | 13.09x | 15.83B | |
| 0.93% | 1.16% | 23.93x | 2.69x | 0.96x | 16.17x | 16.48x | 7.38B | |
| 2.29% | 2.63% | 16.29x | 1.71x | 0.73x | 7.61x | 9.56x | 6.21B | |
| 3.06% | 3.37% | 13.84x | 2.1x | 0.9x | 6.47x | 8.48x | 3.98B | |
| 5.9% | 5.94% | 15.04x | 4.92x | 1.3x | 8x | 14.84x | 3.3B | |
| 4.31% | 4.73% | 14.88x | 6.73x | 0.9x | 6.76x | 9.41x | 3.12B | |
| 1.92% | 2.33% | 21.36x | 3.74x | 0.62x | 7.92x | 12.97x | 1.59B | |
| 0.02% | -.--% | -103x | 2.69x | 0.45x | 16.38x | 70.51x | 1.5B | |
| 4.17% | 4.7% | 12.16x | 0.87x | 0.29x | 2.8x | 5.77x | 966M | |
| 5.75% | 5.57% | 14.51x | 2.4x | 0.85x | 6.92x | 14.88x | 919M | |
| 1.36% | 1.96% | 26.4x | 7.2x | 0.96x | 13.03x | 20.2x | 810M | |
| 0.37% | 0.36% | 13.85x | 1.87x | 0.67x | 8.2x | 13.23x | 698M | |
| Average | 2.71% | 2.96% | 7.76x | 3.16x | 0.76x | 8.99x | 16.66x | 3.79B | |
| Weighted average by Cap. | 1.93% | 2.12% | 14.08x | 2.62x | 0.81x | 10.32x | 14.06x |
Select your edition
All financial news and data tailored to specific country editions
